Vanderbilt University Recruits Glaucoma Patients for Allergan Medication Using Novel ‘Dropless’ Method

Nov 11, 2019 | Glaucoma, High Eye Pressure, Ophthalmology, Vanderbilt University

Vanderbilt University Recruits Glaucoma Patients for Allergan Medication Using Novel ‘Dropless’ Method

Vanderbilt University Medical Center seeks patients diagnosed with Ocular Hypertension or Angle Glaucoma for a study testing a new dropless delivery method for eye pressure. Called the “Triton” research study, it entails 36 visits over a 30 month period.

The Study

The study involves a dropless delivery method for a branded medication (Bimatoprost sustained release) manufactured by Allegan. Those participating will receive medication for high eye pressure at no cost and may even be eligible for compensation. Scott Ruark coordinates the clinical trial for Vanderbilt.

Call to Action: Those that have high eye pressure residing in the Nashville, TN, area may want to consider this study and contact Scott Ruark. This is a national study sponsored by Allergan.

1 Comment

  1. Richard

    I’ve been asked to consider participating in this trial in Boston and would like to learn my responsibilities.

Pin It on Pinterest